Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
Lucentis EU approval
Bausch + Lomb app
Prostate cancer cataracts
KERARINGS and CXL successful


Survey

Would you consider using Lucentis for the treatment of DME?
Click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.

Click here to contact Neil Hanley, sales manager.

January 19, 2011
EU approval for use of Lucentis to treat DME
Novartis has received the eagerly anticipated from the European Commission for Lucentis (ranibizumab) to treat visual impairment due to diabetic macular oedema (DME). More...
Bausch + Lomb launches iPhone app
Bausch + Lomb has introduced a free iPhone application that will test a patient's visual acuity and colour vision, enable them to learn more about cataracts and Crystalens and find a suitable surgeon. More...
Prostate cancer therapy could cause cataracts
Androgen deprivation therapy (ADT) used for prostate cancer treatment could contribute towards the development of cataracts. More...
Same-session KERARINGS and CXL procedure is effective
Abstract: Combined use of intracorneal ring segments (KERARINGS) and corneal collagen cross-linking (CXL) in a single session is more effective than performing the procedure in two sessions. More...

 

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom